| 1. |
郭大川, 王舒寶. 保留迷走神經的胃癌根治術解剖學研究. 中國實用外科雜志, 1999, 19(3):160-162.
|
| 2. |
Ando S, Tsuji H. Surgical technique of vagus nerve-preserving gastrectomy with D2 lymphadenectomy for gastric cancer. ANZ J Surg, 2008, 78(3):172-176.
|
| 3. |
幕內雅敏(日)監修. 技巧與誤區:胃外科要點與盲點. 段志泉總主譯. 沈陽:遼寧科學技術出版社, 2009:212.
|
| 4. |
翟同善. T3期胃下部癌D2術式選擇性自主神經保留可行性探討. 中國醫科大學學報, 2010, 39(9):773-774.
|
| 5. |
Miwa K, Kinami S, Sato T, et al. Vagus-saving D2 procedure for early gastric carcinoma. Nihon Geka Gakkai Zasshi, 1996, 97(4):286-290.
|
| 6. |
Sasada S, Ninomiya M, Nishizaki M, et al. Survival of patients treated by an autonomic nerve-preserving gastrectomy for early gastric cancer. Surg Today, 2010, 40(5):444-450.
|
| 7. |
Wang L, Zhang W, Quan C, et al. Quality of life and prognosis after celiac branch of vagus preserving distal radical gastrectomy. Eur Surg ACA, 2015, 47 Suppl 1:S11.
|
| 8. |
Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth Ⅰ gastrectomy. Surg Laparosc Endosc, 1994, 4(2):146-148.
|
| 9. |
Takiguchi S, Hiura Y, Takahashi T, et al. Preservation of the celiac branch of the vagus nerve during laparoscopy-assisted distal gastrec-tomy:impact on postprandial changes in ghrelin secretion. World J Surg, 2013, 37(9):2172-2179.
|
| 10. |
Kim SM, Cho J, Kang D, et al. A randomized controlled trial of vagus nerve-preserving distal gastrectomy versus conventional distal gastrectomy for postoperative quality of life in early stage gastric cancer patients. Ann Surg, 2016, 263(6):1079-1084.
|
| 11. |
房學東, 王旭東, 劉卓. 保留迷走神經的遠端胃癌根治術的臨床研究. 消化腫瘤雜志:電子版, 2009, 1(1):24-28.
|
| 12. |
謝小平, 朱國民, 吳厚斌, 等. 保留迷走神經的遠端胃癌根治術對早期胃癌的療效觀察. 江西醫藥, 2015, 50(7):620-623.
|
| 13. |
Kojima K, Yamada H, Inokuchi M, et al. Functional evaluation after vagus-nerve-sparing laparoscopically assisted distal gastrectomy. Surg Endosc, 2008, 22(9):2003-2008.
|
| 14. |
Pavlov VA, Wang H, Czura CJ, et al. The cholinergic anti-inflamma-tory pathway:a missing link in neuroimmunomodulation. Mol Med, 2003, 9(5-8):125-134.
|
| 15. |
van Westerloo DJ, Giebelen IA, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis, 2005, 191(12):2138-2148.
|
| 16. |
Kessler W, Traeger T, Westerholt A, et al. The vagal nerve as a link between the nervous and immune system in the instance of polymicrobial sepsis. Langenbecks Arch Surg, 2006, 391(2):83-87.
|
| 17. |
Fujita T, Yanaga K. Clinical influence of vagotomy on postoperative acute phase response. Langenbecks Arch Surg, 2007, 392(2):127-130.
|
| 18. |
繩繼健, 孫國瑞, 何慶泗, 等. 胃癌根治術保留迷走神經對術后急性炎癥反應的影響研究. 中國現代普通外科進展, 2012, 15(9):703-706.
|
| 19. |
Goverse G, Stakenborg M, Matteoli G. The intestinal cholinergic anti-inflammatory pathway. J Physiol, 2016 Mar 9.
|
| 20. |
Kim HH, Park MI, Lee SH, et al. Effects of vagus nerve preservation and vagotomy on peptide YY and body weight after subtotal gastrectomy. World J Gastroenterol, 2012, 18(30):4044-4050.
|
| 21. |
Zhang T, Uchida T, Gomez G, et al. Neural regulation of peptide YY secretion. Regul Pept, 1993, 48(3):321-328.
|
| 22. |
Batterham RL, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature, 2002, 418(6898):650-654.
|
| 23. |
Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med, 2003, 349(10):941-948.
|
| 24. |
胡英斌, 江勃年, 唐自元, 等. 保留迷走神經腹腔支胃癌根治術的臨床研究. 中國現代手術學雜志, 2011, 15(2):98-100.
|
| 25. |
吳厚賓, 謝小平, 朱國民, 等. 保留迷走神經遠端胃癌根治術患者的營養及預后. 廣東醫學, 2014, 35(12):1923-1925.
|
| 26. |
Aly A, Shulkes A, Baldwin GS. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta, 2004, 1704(1):1-10.
|
| 27. |
Cowey SL, Quast M, Belalcazar LM, et al. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer, 2005, 103(12):2643-2653.
|
| 28. |
Gaddipati KV, Simonian HP, Kresge KM, et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci, 2006, 51(8):1339-1346.
|
| 29. |
Taylor IL, Impicciatore M, Carter DC, et al. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol, 1978, 235(4):E443-E447.
|
| 30. |
Ihasz M, Griffith CA. Gallstones after vagotomy. Am J Surg, 1981, 141(1):48-50.
|
| 31. |
Tsuji H, Andoh S, Sakakibara K, et al. The clinical evaluation of vagus nerve preserving gastric operation with d2 lymph node dissec-tion for early and advanced gastric cancer. Nippon Shokaki Geka Gakkai Zasshi, 2003, 36(2):78-84.
|
| 32. |
Tomita R, Fujisaki S, Koshinaga T, et al. Clinical assessments in pati-ents ten years after pylorus-preserving gastrectomy with or without preserving both pyloric and hepatic branches of the vagal nerve for early gastric cancer. Hepatogastroenterology, 2010, 57(11):984-988.
|
| 33. |
Chen XJ, Li N, Huang YD, et al. Factors for postoperative gallstone occurrence in patients with gastric cancer:a meta-analysis. Asian Pac J Cancer Prev, 2014, 15(2):877-881.
|
| 34. |
呂云福, 董永紅, 黃海, 等. 賁門周圍血管離斷術后胃動力障礙的病因分析與預防措施. 中華普通外科雜志, 2003, 18(9):553-555.
|
| 35. |
Murakami H, Matsumoto H, Kubota H, et al. Evaluation of electrical activity after vagus nerve-preserving distal gastrectomy using multi-channel electrogastrography. J Smooth Muscle Res, 2013, 49:1-14.
|
| 36. |
桑溫昌, 李兆德, 宮東堯, 等. 保留迷走神經的全胃切除術療效分析. 中華臨床醫師雜志:電子版, 2011, 5(8):2232-2235.
|
| 37. |
Hiki N, Nunobe S, Kubota T, et al. Function-preserving gastrectomy for early gastric cancer. Ann Surg Oncol, 2013, 20(8):2683-2692.
|
| 38. |
Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery:morbi-dity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol, 2004, 22(14):2767-2773.
|